-
1
-
-
79952717349
-
Fibrosis, AEJACoIP., An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
-
Raghu, G., Collard, H.R., Egan, J.J., Martinez, F.J., Behr, J., Brown, K.K., Colby, T.V., Cordier, J.F., Flaherty, K.R., Lasky, J.A., Lynch, D.A., Ryu, J.H., Swigris, J.J., Wells, A.U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D.M., Johkoh, T., Kim, D.S., King, T.E. Jr., Kondoh, Y., Myers, J., Muller, N.L., Nicholson, A.G., Richeldi, L., Selman, M., Dudden, R.F., Griss, B.S., Protzko, S.L., Schunemann, H.J., Fibrosis, AEJACoIP., An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. care Med. 183 (2011), 788–824.
-
(2011)
Am. J. Respir. Crit. care Med.
, vol.183
, pp. 788-824
-
-
Raghu, G.1
Collard, H.R.2
Egan, J.J.3
Martinez, F.J.4
Behr, J.5
Brown, K.K.6
Colby, T.V.7
Cordier, J.F.8
Flaherty, K.R.9
Lasky, J.A.10
Lynch, D.A.11
Ryu, J.H.12
Swigris, J.J.13
Wells, A.U.14
Ancochea, J.15
Bouros, D.16
Carvalho, C.17
Costabel, U.18
Ebina, M.19
Hansell, D.M.20
Johkoh, T.21
Kim, D.S.22
King, T.E.23
Kondoh, Y.24
Myers, J.25
Muller, N.L.26
Nicholson, A.G.27
Richeldi, L.28
Selman, M.29
Dudden, R.F.30
Griss, B.S.31
Protzko, S.L.32
Schunemann, H.J.33
more..
-
2
-
-
84870765540
-
Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature
-
Nalysnyk, L., Cid-Ruzafa, J., Rotella, P., Esser, D., Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature. Eur. Respir. Rev. official J. Eur. Respir. Soc. 21 (2012), 355–361.
-
(2012)
Eur. Respir. Rev. official J. Eur. Respir. Soc.
, vol.21
, pp. 355-361
-
-
Nalysnyk, L.1
Cid-Ruzafa, J.2
Rotella, P.3
Esser, D.4
-
3
-
-
33749444308
-
Incidence and prevalence of idiopathic pulmonary fibrosis
-
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W.Z., Oster, G., Incidence and prevalence of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. care Med. 174 (2006), 810–816.
-
(2006)
Am. J. Respir. Crit. care Med.
, vol.174
, pp. 810-816
-
-
Raghu, G.1
Weycker, D.2
Edelsberg, J.3
Bradford, W.Z.4
Oster, G.5
-
4
-
-
84891373517
-
Idiopathic pulmonary fibrosis: on the move
-
Bouros, D., Tzouvelekis, A., Idiopathic pulmonary fibrosis: on the move. lancet Respir. Med. 2 (2014), 17–19.
-
(2014)
lancet Respir. Med.
, vol.2
, pp. 17-19
-
-
Bouros, D.1
Tzouvelekis, A.2
-
5
-
-
84923310446
-
Idiopathic pulmonary fibrosis: an update
-
Spagnolo, P., Sverzellati, N., Rossi, G., Cavazza, A., Tzouvelekis, A., Crestani, B., Vancheri, C., Idiopathic pulmonary fibrosis: an update. Ann. Med. 47 (2015), 15–27.
-
(2015)
Ann. Med.
, vol.47
, pp. 15-27
-
-
Spagnolo, P.1
Sverzellati, N.2
Rossi, G.3
Cavazza, A.4
Tzouvelekis, A.5
Crestani, B.6
Vancheri, C.7
-
6
-
-
84942884150
-
Personalized medicine in idiopathic pulmonary fibrosis: facts and promises
-
Spagnolo, P., Tzouvelekis, A., Maher, T.M., Personalized medicine in idiopathic pulmonary fibrosis: facts and promises. Curr. Opin. Pulm. Med. 21 (2015), 470–478.
-
(2015)
Curr. Opin. Pulm. Med.
, vol.21
, pp. 470-478
-
-
Spagnolo, P.1
Tzouvelekis, A.2
Maher, T.M.3
-
7
-
-
84924744009
-
Update on therapeutic management of idiopathic pulmonary fibrosis
-
Tzouvelekis, A., Bonella, F., Spagnolo, P., Update on therapeutic management of idiopathic pulmonary fibrosis. Ther. Clin. risk Manag. 11 (2015), 359–370.
-
(2015)
Ther. Clin. risk Manag.
, vol.11
, pp. 359-370
-
-
Tzouvelekis, A.1
Bonella, F.2
Spagnolo, P.3
-
8
-
-
84881373734
-
Anti-acid treatment for idiopathic pulmonary fibrosis
-
Tzouvelekis, A., Bouros, D., Anti-acid treatment for idiopathic pulmonary fibrosis. lancet Respir. Med. 1 (2013), 348–349.
-
(2013)
lancet Respir. Med.
, vol.1
, pp. 348-349
-
-
Tzouvelekis, A.1
Bouros, D.2
-
9
-
-
84964226751
-
Biomarkers in the evaluation and management of idiopathic pulmonary fibrosis
-
Tzouvelekis, A., Herazo-Maya, J., Sakamoto, K., Bouros, D., Biomarkers in the evaluation and management of idiopathic pulmonary fibrosis. Curr. Top. Med. Chem. 16 (2016), 1587–1598.
-
(2016)
Curr. Top. Med. Chem.
, vol.16
, pp. 1587-1598
-
-
Tzouvelekis, A.1
Herazo-Maya, J.2
Sakamoto, K.3
Bouros, D.4
-
10
-
-
84987662350
-
Lung transplantation in IIP: a review
-
Brown, A.W., Kaya, H., Nathan, S.D., Lung transplantation in IIP: a review. Respirology 21 (2016), 1173–1184.
-
(2016)
Respirology
, vol.21
, pp. 1173-1184
-
-
Brown, A.W.1
Kaya, H.2
Nathan, S.D.3
-
11
-
-
85006423756
-
Diagnostic and prognostic challenges in Idiopathic Pulmonary Fibrosis A patient “Q and A” approach
-
Tzouvelekis, A., Tzilas, V., Papiris, S., Aidinis, V., Bouros, D., Diagnostic and prognostic challenges in Idiopathic Pulmonary Fibrosis A patient “Q and A” approach. Pulm. Pharmacol. Ther. 42 (2017), 21–24.
-
(2017)
Pulm. Pharmacol. Ther.
, vol.42
, pp. 21-24
-
-
Tzouvelekis, A.1
Tzilas, V.2
Papiris, S.3
Aidinis, V.4
Bouros, D.5
-
12
-
-
84959333352
-
Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis
-
Lehtonen, S.T., Veijola, A., Karvonen, H., Lappi-Blanco, E., Sormunen, R., Korpela, S., Zagai, U., Skold, M.C., Kaarteenaho, R., Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis. Respir. Res., 17, 2016, 14.
-
(2016)
Respir. Res.
, vol.17
, pp. 14
-
-
Lehtonen, S.T.1
Veijola, A.2
Karvonen, H.3
Lappi-Blanco, E.4
Sormunen, R.5
Korpela, S.6
Zagai, U.7
Skold, M.C.8
Kaarteenaho, R.9
-
13
-
-
0032842405
-
Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis
-
Iyer, S.N., Gurujeyalakshmi, G., Giri, S.N., Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J. Pharmacol. Exp. Ther. 291 (1999), 367–373.
-
(1999)
J. Pharmacol. Exp. Ther.
, vol.291
, pp. 367-373
-
-
Iyer, S.N.1
Gurujeyalakshmi, G.2
Giri, S.N.3
-
14
-
-
85015353035
-
Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models
-
Yu, W., Guo, F., Song, X., Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models. Pharm. Biol. 55 (2017), 450–455.
-
(2017)
Pharm. Biol.
, vol.55
, pp. 450-455
-
-
Yu, W.1
Guo, F.2
Song, X.3
-
15
-
-
48149113955
-
Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
-
Oku, H., Shimizu, T., Kawabata, T., Nagira, M., Hikita, I., Ueyama, A., Matsushima, S., Torii, M., Arimura, A., Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur. J. Pharmacol. 590 (2008), 400–408.
-
(2008)
Eur. J. Pharmacol.
, vol.590
, pp. 400-408
-
-
Oku, H.1
Shimizu, T.2
Kawabata, T.3
Nagira, M.4
Hikita, I.5
Ueyama, A.6
Matsushima, S.7
Torii, M.8
Arimura, A.9
-
16
-
-
79956356774
-
Pirfenidone for idiopathic pulmonary fibrosis
-
Bouros, D., Pirfenidone for idiopathic pulmonary fibrosis. Lancet 377 (2011), 1727–1729.
-
(2011)
Lancet
, vol.377
, pp. 1727-1729
-
-
Bouros, D.1
-
17
-
-
20944434994
-
Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis
-
Azuma, A., Nukiwa, T., Tsuboi, E., Suga, M., Abe, S., Nakata, K., Taguchi, Y., Nagai, S., Itoh, H., Ohi, M., Sato, A., Kudoh, S., Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. care Med. 171 (2005), 1040–1047.
-
(2005)
Am. J. Respir. Crit. care Med.
, vol.171
, pp. 1040-1047
-
-
Azuma, A.1
Nukiwa, T.2
Tsuboi, E.3
Suga, M.4
Abe, S.5
Nakata, K.6
Taguchi, Y.7
Nagai, S.8
Itoh, H.9
Ohi, M.10
Sato, A.11
Kudoh, S.12
-
18
-
-
84901759236
-
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
-
King, T.E. Jr., Bradford, W.Z., Castro-Bernardini, S., Fagan, E.A., Glaspole, I., Glassberg, M.K., Gorina, E., Hopkins, P.M., Kardatzke, D., Lancaster, L., Lederer, D.J., Nathan, S.D., Pereira, C.A., Sahn, S.A., Sussman, R., Swigris, J.J., Noble, P.W., Group, A.S., A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 370 (2014), 2083–2092.
-
(2014)
N. Engl. J. Med.
, vol.370
, pp. 2083-2092
-
-
King, T.E.1
Bradford, W.Z.2
Castro-Bernardini, S.3
Fagan, E.A.4
Glaspole, I.5
Glassberg, M.K.6
Gorina, E.7
Hopkins, P.M.8
Kardatzke, D.9
Lancaster, L.10
Lederer, D.J.11
Nathan, S.D.12
Pereira, C.A.13
Sahn, S.A.14
Sussman, R.15
Swigris, J.J.16
Noble, P.W.17
Group, A.S.18
-
19
-
-
79956341531
-
Group CS. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
-
Noble, P.W., Albera, C., Bradford, W.Z., Costabel, U., Glassberg, M.K., Kardatzke, D., King, T.E. Jr., Lancaster, L., Sahn, S.A., Szwarcberg, J., Valeyre, D., du Bois, R.M., Group CS. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 377 (2011), 1760–1769.
-
(2011)
Lancet
, vol.377
, pp. 1760-1769
-
-
Noble, P.W.1
Albera, C.2
Bradford, W.Z.3
Costabel, U.4
Glassberg, M.K.5
Kardatzke, D.6
King, T.E.7
Lancaster, L.8
Sahn, S.A.9
Szwarcberg, J.10
Valeyre, D.11
du Bois, R.M.12
-
20
-
-
77951160564
-
Pirfenidone clinical study group in j. Pirfenidone in idiopathic pulmonary fibrosis
-
Taniguchi, H., Ebina, M., Kondoh, Y., Ogura, T., Azuma, A., Suga, M., Taguchi, Y., Takahashi, H., Nakata, K., Sato, A., Takeuchi, M., Raghu, G., Kudoh, S., Nukiwa, T., Pirfenidone clinical study group in j. Pirfenidone in idiopathic pulmonary fibrosis. Eur. Respir. J. 35 (2010), 821–829.
-
(2010)
Eur. Respir. J.
, vol.35
, pp. 821-829
-
-
Taniguchi, H.1
Ebina, M.2
Kondoh, Y.3
Ogura, T.4
Azuma, A.5
Suga, M.6
Taguchi, Y.7
Takahashi, H.8
Nakata, K.9
Sato, A.10
Takeuchi, M.11
Raghu, G.12
Kudoh, S.13
Nukiwa, T.14
-
21
-
-
84938125365
-
American Thoracic S, European respiratory s, Japanese respiratory S, Latin American Thoracic a. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline
-
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C.A., Azuma, A., Behr, J., Brozek, J.L., Collard, H.R., Cunningham, W., Homma, S., Johkoh, T., Martinez, F.J., Myers, J., Protzko, S.L., Richeldi, L., Rind, D., Selman, M., Theodore, A., Wells, A.U., Hoogsteden, H., Schunemann, H.J., American Thoracic S, European respiratory s, Japanese respiratory S, Latin American Thoracic a. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am. J. Respir. Crit. care Med. 192 (2015), e3–19.
-
(2015)
Am. J. Respir. Crit. care Med.
, vol.192
, pp. e3-19
-
-
Raghu, G.1
Rochwerg, B.2
Zhang, Y.3
Garcia, C.A.4
Azuma, A.5
Behr, J.6
Brozek, J.L.7
Collard, H.R.8
Cunningham, W.9
Homma, S.10
Johkoh, T.11
Martinez, F.J.12
Myers, J.13
Protzko, S.L.14
Richeldi, L.15
Rind, D.16
Selman, M.17
Theodore, A.18
Wells, A.U.19
Hoogsteden, H.20
Schunemann, H.J.21
more..
-
22
-
-
84883054431
-
Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice
-
Okuda, R., Hagiwara, E., Baba, T., Kitamura, H., Kato, T., Ogura, T., Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice. Respir. Med. 107 (2013), 1431–1437.
-
(2013)
Respir. Med.
, vol.107
, pp. 1431-1437
-
-
Okuda, R.1
Hagiwara, E.2
Baba, T.3
Kitamura, H.4
Kato, T.5
Ogura, T.6
-
23
-
-
84920409063
-
Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis
-
Loeh, B., Drakopanagiotakis, F., Bandelli, G.P., von der Beck, D., Tello, S., Cordani, E., Rizza, E., Barrocu, L., Markart, P., Seeger, W., Guenther, A., Albera, C., Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. care Med. 191 (2015), 110–113.
-
(2015)
Am. J. Respir. Crit. care Med.
, vol.191
, pp. 110-113
-
-
Loeh, B.1
Drakopanagiotakis, F.2
Bandelli, G.P.3
von der Beck, D.4
Tello, S.5
Cordani, E.6
Rizza, E.7
Barrocu, L.8
Markart, P.9
Seeger, W.10
Guenther, A.11
Albera, C.12
-
24
-
-
84887573050
-
Efficacy of pirfenidone in patients with advanced-stage idiopathic pulmonary fibrosis
-
Sakamoto, S., Itoh, T., Muramatsu, Y., Satoh, K., Ishida, F., Sugino, K., Isobe, K., Homma, S., Efficacy of pirfenidone in patients with advanced-stage idiopathic pulmonary fibrosis. Intern. Med. 52 (2013), 2495–2501.
-
(2013)
Intern. Med.
, vol.52
, pp. 2495-2501
-
-
Sakamoto, S.1
Itoh, T.2
Muramatsu, Y.3
Satoh, K.4
Ishida, F.5
Sugino, K.6
Isobe, K.7
Homma, S.8
-
25
-
-
84930759119
-
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: an Italian real life study
-
Harari, S., Caminati, A., Albera, C., Vancheri, C., Poletti, V., Pesci, A., Luppi, F., Saltini, C., Agostini, C., Bargagli, E., Sebastiani, A., Sanduzzi, A., Giunta, V., Della Porta, R., Bandelli, G.P., Puglisi, S., Tomassetti, S., Biffi, A., Cerri, S., Mari, A., Cinetto, F., Tirelli, F., Farinelli, G., Bocchino, M., Specchia, C., Confalonieri, M., Efficacy of pirfenidone for idiopathic pulmonary fibrosis: an Italian real life study. Respir. Med. 109 (2015), 904–913.
-
(2015)
Respir. Med.
, vol.109
, pp. 904-913
-
-
Harari, S.1
Caminati, A.2
Albera, C.3
Vancheri, C.4
Poletti, V.5
Pesci, A.6
Luppi, F.7
Saltini, C.8
Agostini, C.9
Bargagli, E.10
Sebastiani, A.11
Sanduzzi, A.12
Giunta, V.13
Della Porta, R.14
Bandelli, G.P.15
Puglisi, S.16
Tomassetti, S.17
Biffi, A.18
Cerri, S.19
Mari, A.20
Cinetto, F.21
Tirelli, F.22
Farinelli, G.23
Bocchino, M.24
Specchia, C.25
Confalonieri, M.26
more..
-
26
-
-
84896048835
-
Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis
-
Arai, T., Inoue, Y., Sasaki, Y., Tachibana, K., Nakao, K., Sugimoto, C., Okuma, T., Akira, M., Kitaichi, M., Hayashi, S., Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis. Respir. Investig. 52 (2014), 136–143.
-
(2014)
Respir. Investig.
, vol.52
, pp. 136-143
-
-
Arai, T.1
Inoue, Y.2
Sasaki, Y.3
Tachibana, K.4
Nakao, K.5
Sugimoto, C.6
Okuma, T.7
Akira, M.8
Kitaichi, M.9
Hayashi, S.10
-
27
-
-
79960556065
-
Pirfenidone Clinical Study Group in J. The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial
-
Taniguchi, H., Kondoh, Y., Ebina, M., Azuma, A., Ogura, T., Taguchi, Y., Suga, M., Takahashi, H., Nakata, K., Sato, A., Sugiyama, Y., Kudoh, S., Nukiwa, T., Pirfenidone Clinical Study Group in J. The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial. Respir. Res., 12, 2011, 93.
-
(2011)
Respir. Res.
, vol.12
, pp. 93
-
-
Taniguchi, H.1
Kondoh, Y.2
Ebina, M.3
Azuma, A.4
Ogura, T.5
Taguchi, Y.6
Suga, M.7
Takahashi, H.8
Nakata, K.9
Sato, A.10
Sugiyama, Y.11
Kudoh, S.12
Nukiwa, T.13
-
28
-
-
85043559415
-
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials
-
Lancaster, L., Albera, C., Bradford, W.Z., Costabel, U., du Bois, R.M., Fagan, E.A., Fishman, R.S., Glaspole, I., Glassberg, M.K., King, T.E. Jr., Lederer, D.J., Lin, Z., Nathan, S.D., Pereira, C.A., Swigris, J.J., Valeyre, D., Noble, P.W., Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials. BMJ Open Respir. Res., 3, 2016, e000105.
-
(2016)
BMJ Open Respir. Res.
, vol.3
, pp. e000105
-
-
Lancaster, L.1
Albera, C.2
Bradford, W.Z.3
Costabel, U.4
du Bois, R.M.5
Fagan, E.A.6
Fishman, R.S.7
Glaspole, I.8
Glassberg, M.K.9
King, T.E.10
Lederer, D.J.11
Lin, Z.12
Nathan, S.D.13
Pereira, C.A.14
Swigris, J.J.15
Valeyre, D.16
Noble, P.W.17
-
29
-
-
84923857080
-
Analysis of lung function and survival in RECAP: an open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis
-
Costabel, U., Albera, C., Bradford, W.Z., Hormel, P., King, T.E. Jr., Noble, P.W., Sahn, S.A., Valeyre, D., du Bois, R.M., Analysis of lung function and survival in RECAP: an open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis. Sarcoidosis, Vasc. diffuse lung Dis. official J. WASOG/World Assoc. Sarcoidosis Other Granulomatous Disord. 31 (2014), 198–205.
-
(2014)
Sarcoidosis, Vasc. diffuse lung Dis. official J. WASOG/World Assoc. Sarcoidosis Other Granulomatous Disord.
, vol.31
, pp. 198-205
-
-
Costabel, U.1
Albera, C.2
Bradford, W.Z.3
Hormel, P.4
King, T.E.5
Noble, P.W.6
Sahn, S.A.7
Valeyre, D.8
du Bois, R.M.9
-
30
-
-
79952717349
-
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
-
Raghu, G., Collard, H.R., Egan, J.J., Martinez, F.J., Behr, J., Brown, K.K., Colby, T.V., Cordier, J.F., Flaherty, K.R., Lasky, J.A., Lynch, D.A., Ryu, J.H., Swigris, J.J., Wells, A.U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D.M., Johkoh, T., Kim, D.S., King, T.E. Jr., Kondoh, Y., Myers, J., Muller, N.L., Nicholson, A.G., Richeldi, L., Selman, M., Dudden, R.F., Griss, B.S., Protzko, S.L., Schunemann, H.J., An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. care Med. 183 (2011), 788–824.
-
(2011)
Am. J. Respir. Crit. care Med.
, vol.183
, pp. 788-824
-
-
Raghu, G.1
Collard, H.R.2
Egan, J.J.3
Martinez, F.J.4
Behr, J.5
Brown, K.K.6
Colby, T.V.7
Cordier, J.F.8
Flaherty, K.R.9
Lasky, J.A.10
Lynch, D.A.11
Ryu, J.H.12
Swigris, J.J.13
Wells, A.U.14
Ancochea, J.15
Bouros, D.16
Carvalho, C.17
Costabel, U.18
Ebina, M.19
Hansell, D.M.20
Johkoh, T.21
Kim, D.S.22
King, T.E.23
Kondoh, Y.24
Myers, J.25
Muller, N.L.26
Nicholson, A.G.27
Richeldi, L.28
Selman, M.29
Dudden, R.F.30
Griss, B.S.31
Protzko, S.L.32
Schunemann, H.J.33
more..
-
31
-
-
79956341531
-
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
-
Noble, P.W., Albera, C., Bradford, W.Z., Costabel, U., Glassberg, M.K., Kardatzke, D., King, T.E. Jr., Lancaster, L., Sahn, S.A., Szwarcberg, J., Valeyre, D., du Bois, R.M., Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 377 (2011), 1760–1769.
-
(2011)
Lancet
, vol.377
, pp. 1760-1769
-
-
Noble, P.W.1
Albera, C.2
Bradford, W.Z.3
Costabel, U.4
Glassberg, M.K.5
Kardatzke, D.6
King, T.E.7
Lancaster, L.8
Sahn, S.A.9
Szwarcberg, J.10
Valeyre, D.11
du Bois, R.M.12
-
32
-
-
85006070790
-
Clinical features and outcomes of IPF patients hospitalized for pulmonary infection: a Japanese cohort study
-
Yamazaki, R., Nishiyama, O., Sano, H., Iwanaga, T., Higashimoto, Y., Kume, H., Tohda, Y., Clinical features and outcomes of IPF patients hospitalized for pulmonary infection: a Japanese cohort study. PLoS One, 11, 2016, e0168164.
-
(2016)
PLoS One
, vol.11
, pp. e0168164
-
-
Yamazaki, R.1
Nishiyama, O.2
Sano, H.3
Iwanaga, T.4
Higashimoto, Y.5
Kume, H.6
Tohda, Y.7
-
33
-
-
84994528757
-
Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities
-
King, C.S., Nathan, S.D., Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities. lancet Respir. Med. 5 (2017), 72–84.
-
(2017)
lancet Respir. Med.
, vol.5
, pp. 72-84
-
-
King, C.S.1
Nathan, S.D.2
-
34
-
-
84988884607
-
Precision medicine: the new frontier in idiopathic pulmonary fibrosis
-
Brownell, R., Kaminski, N., Woodruff, P.G., Bradford, W.Z., Richeldi, L., Martinez, F.J., Collard, H.R., Precision medicine: the new frontier in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. care Med. 193 (2016), 1213–1218.
-
(2016)
Am. J. Respir. Crit. care Med.
, vol.193
, pp. 1213-1218
-
-
Brownell, R.1
Kaminski, N.2
Woodruff, P.G.3
Bradford, W.Z.4
Richeldi, L.5
Martinez, F.J.6
Collard, H.R.7
-
35
-
-
38449102031
-
Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
-
Shorr, A.F., Wainright, J.L., Cors, C.S., Lettieri, C.J., Nathan, S.D., Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur. Respir. J. 30 (2007), 715–721.
-
(2007)
Eur. Respir. J.
, vol.30
, pp. 715-721
-
-
Shorr, A.F.1
Wainright, J.L.2
Cors, C.S.3
Lettieri, C.J.4
Nathan, S.D.5
-
36
-
-
33645118315
-
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
-
Lettieri, C.J., Nathan, S.D., Barnett, S.D., Ahmad, S., Shorr, A.F., Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129 (2006), 746–752.
-
(2006)
Chest
, vol.129
, pp. 746-752
-
-
Lettieri, C.J.1
Nathan, S.D.2
Barnett, S.D.3
Ahmad, S.4
Shorr, A.F.5
|